Levitee Labs Inc. (CNSX:LVT) entered into a letter of intent to acquire 51% of the issued and outstanding shares in Compounding Pharmacy in Calgary, Alberta, Canada for CAD 0.306 million on October 12, 2021. In the agreement, Levitee will pay CAD 0.306 million in cash for 51% of the issued and outstanding shares in the pharmacy, equating to approximately 3.5x TTM EBITDA. Levitee expects to fund this acquisition using its current cash reserves. This LOI is non-binding and remains subject to the drafting of definitive agreements, approval from Levitee Labs? board, and regulatory body approvals.